E-poster No. / 壁報編號
B016
Title / 題目
The application of a PI3K inhibitor and an AKT inhibitor in HER2-positive breast cancer cells with resistance to HER2-directed antibody-drug conjugates
First Author / 第一作者
Wei-Pang Chung
Institution / 單位
1. Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
2. Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan
Audio / 音訊檔
Author Group / 作者群
Wei-Pang Chung1,2, Wei-Lun Huang2, 3, Chun-Hui Lee1, 2, 4, Hui-Ping Hsu5, Kuo-Ting Lee5, Zhu-Jun Loh5, Wan-Ling Huang2, You-Yu Liu2,6
Author Group Institution/ 作者群單位
1. Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
2. Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.
3. Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
4. Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
5. Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
6. Institute of Basic Medical Science, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Category / 主題分類
Basic Research
Keyword / 關鍵字
Breast cancer, HER2, PI3K, AKT, PIK3CA, antibody-drug conjugate, resistance
